Monitoring and managing metabolic effects of antipsychotics: a cluster randomized trial of an intervention combining evidence-based quality improvement and external facilitation

BACKGROUND: Treatment of psychotic disorders consists primarily of second generation antipsychotics, which are associated with metabolic side effects such as overweight/obesity, diabetes, and dyslipidemia. Evidence-based clinical practice guidelines recommend timely assessment and management of thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Owen, Richard R, Drummond, Karen L, Viverito, Kristen M, Marchant, Kathy, Pope, Sandra K, Smith, Jeffrey L, Landes, Reid D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852845/
https://www.ncbi.nlm.nih.gov/pubmed/24103648
http://dx.doi.org/10.1186/1748-5908-8-120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852845/
https://www.ncbi.nlm.nih.gov/pubmed/24103648
http://dx.doi.org/10.1186/1748-5908-8-120

Ejemplares similares